|
|
||||||||
1 Saint Louis Zoo, One Government Drive, Saint Louis, Missouri 63110, USA
2 College of Veterinary Medicine, University of Missouri, 203 Veterinary Medicine Building, Columbia, Missouri 65211, USA
3 Wildlife Conservation Research Unit, University of Oxford, Tubney House, Abingdon Road, OX13 5QL, UK
4 Department of Biology, University of MissouriSaint Louis, 8001 Natural Bridge Road, Saint Louis, Missouri 63121, USA
5 Institute of Ecology, The University of Georgia, Athens, GA 30602, USA
7 Corresponding author (email: erikazoovet{at}yahoo.com)
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCION |
|---|
|
|
|---|
No avian species have become extinct from the Galápagos Islands (Wikelski et al., 2004), but the possibility of disease causing significant morbidity and mortality is of great concern. Avian health studies in the Galápagos Islands have been ongoing since 2001, and to date, 16 avian species on 11 islands have been sampled. The first comprehensive health assessment of the penguin population occurred in August 2003 and March 2004. Serologic tests were determined from previous penguin disease surveys (Austin and Webster, 1993; Wallace et al., 1997; Clarke and Kerry, 2000; Gauthier-Clerc et al., 2002; Tuttle et al., 2005). Penguins also were tested for exposure to multiple poultry pathogens that could be associated with chickens in the Galápagos Islands (Gottdenker et al., 2005). Potential spillover of poultry pathogens to penguins exists via poultry waste or other infective material in freshwater runoff, aerosol transmission of viruses from inhabited coastal regions adjacent to penguins, discarded poultry products from commercial (fishing and tour) boats in areas where penguins reside, and contact with volant birds (i.e., yellow warblers or finches) that might transmit pathogens of poultry origin to penguin nesting sites. Serologic test selection was also directed by positive serologic results from other endemic Galápagos avian species (Padilla et al., 2003, 2004). In order to establish a baseline for future monitoring of the endangered Galápagos penguin, hematology and serum chemistry parameters also are reported.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Galápagos penguins were studied on the coasts of Isabela (0°25'30''S, 91°7'W) and Fernandina (0°22'0''S, 91°31'20''W) Islands. All sampling procedures were in accordance with Saint Louis Zoo institutional animal care and use committee standards. Eighty-four and 112 penguins were examined in August 2003 and March 2004, respectively. On Fernandina Island, 27 penguins in 2003 and seven in 2004 were sampled, and on Isabela Island, 57 penguins in 2003 and 105 in 2004 were evaluated. Information on capture technique (Vargas et al., 2005), and morphometric measurements and aging (Boersma, 1977), has previously been described. During manual restraint, a transponder (AVID Microchip, Folsom, Louisiana, USA) was placed subcutaneously over the left dorsal mid phalangeal area and the skin defect sealed with tissue glue (3M Vetbond, St Paul, Minnesota, USA). Jugular venipuncture was performed with 20 gauge needles and syringes to collect up to 12 ml of blood per bird. Several drops of blood were immediately placed into cryogenic vials containing a lysis buffer preservative solution (Longmire et al., 1988) for genetic testing of gender, as well as preliminary hemoparasite molecular analysis. During the 2003 field season, whole blood was placed in lithium heparin (Vacutainer PST gel, Becton Dickinson, Franklin Lakes, New Jersey, USA); during the 2004 field season a small amount of whole blood was placed in ethylenediamine-tetraacetic acid (EDTA) (Microtainer gel, Becton Dickinson), and the remainder placed in serum separator tubes (Vacutainer SST gel and clot activator, Becton Dickinson). Blood tubes were kept on ice packs until processing. A single sterile swab (Copan Diagnostics, Corona, California, USA) was used to collect a combined conjunctival, choanal, and cloacal swab per bird (n = 97). The swabs were stored in cryogenic vials (Nalge Nunc International, Rochester, New York, USA). No ectoparasites were observed on feathers during either year. Fecal samples from 11 individual penguins from 2004 were collected opportunistically from fresh excreta during restraint. Feces were preserved in cryogenic vials with potassium dichromate and/or formalin and stored at room temperature for later microscopic examination.
Sample processing
The timing of full sample processing varied from less than 1 hr up to 6 hr after collection. Most samples were centrifuged within 3 hr of collection. Two blood smears were made from whole blood (lithium heparin in 2003, EDTA in 2004), and air dried and fixed with methanol in the field. Microhematocrit tubes (n = 134) were centrifuged (Mobilespin Model 128, Vulcon Technologies, Grandview, Missouri, USA) for 20 min, and the packed cell volumes (PCV) determined. The blood in lysis buffer solution was held at ambient temperature. The lithium heparin whole blood samples (n = 74) and serum separator samples (n = 97) were centrifuged for 20 min, and the plasma or serum decanted and stored in cryogenic vials. The plasma, serum, and swabs were stored in liquid nitrogen in the field and in the laboratory.
Sample and data analysis
Blood smears were stained using a modified WrightGiemsa stain (JorVet Dip-Quick, Jorgensen Laboratories, Loveland, Colorado, USA) at the Saint Louis Zoo for white blood cell (WBC) differentials based on 100 cells counted at 1000x magnification. Blood smears were evaluated for thrombocytes and hemoparasites. Genetic testing for sex determination (n = 157) was performed at the University of MissouriSaint Louis (UMSL) via polymerase chain reaction (PCR) (Fridolfsson and Ellegren, 1999). Ninety of the 2004 samples were processed for serum biochemistry (AVL Veterinary Laboratory, Saint Louis, Missouri, USA), in one batch on the Ace Clinical Chemistry System (Alfa Wassermann, Inc., West Caldwell, New Jersey, USA). Seven results were not included in the analysis due to hemolysis or lipemia.
Serology testing was restricted to the 2004 samples. Testing for antibodies to Chlamydophila psittaci was done by the Texas Veterinary Medical Diagnostic Laboratory, College Station, Texas, USA using direct complement fixation (DCF) on serum (n = 84); combined conjunctival, choanal and cloacal swabs from 30 of the antibody positive penguins were also tested for C. psittaci DNA by real-time PCR.
Serologic tests for viral antibodies, except for WNV, were conducted at the National Veterinary Services Laboratory, US Department of Agriculture, Ames, Iowa, USA. Hemagglutination inhibition (HI) testing was used to test for antibodies to avian paramyxovirus type 13 (n = 75; titers
8 were considered positive) and Venezuelan (VEE), western (WEE), and eastern (EEE) equine encephalitis viruses (n = 26; titers
10 were considered positive). Agar gel immunodiffusion (AGID) testing was used to test for antibodies to avian influenza virus, infectious bursal disease virus, Mareks disease (herpes) virus, avian adenovirus types 1 and 2, and avian encephalomyelitis virus (n = 75). Indirect fluorescent antibody (IFA) testing was used to test for antibodies to reovirus (n = 75). Serum was tested for antibodies to West Nile virus by plaque reduction neutralization (n = 87) at the Animal Health Diagnostic Center, Cornell University, Ithaca, New York, USA. Fecal analysis from fecal floatation and sedimentation was conducted with microscopy at the Southeastern Cooperative Wildlife Disease Study, College of Veterinary Medicine, The University of Georgia, Athens, Georgia, USA.
A statistical software package (NCSS®, Kaysville, Utah, USA) was used for data analysis. Results were inspected for normality using a Shapiro-Wilk W test and t-tests were performed. Mann-Whitney U-tests were used on samples where normality was rejected. A statistical significance was determined as P
0.05 except for the serum chemistry values where a Bonferroni-corrected P
0.004 (0.05/12) was used.
| RESULTS |
|---|
|
|
|---|
|
|
| DISCUSSION |
|---|
|
|
|---|
A change in the Galápagos penguin sampling protocol between years resulted in blood smears from lithium heparin anticoagulated blood in 2003 and EDTA anticoagulated blood in 2004, but no differences were appreciated microscopically between the two anticoagulants. Field conditions did not allow for hemocytometer total WBC counts. An estimated total WBC count from fixed blood smears (Fudge, 2000) was attempted months after sample collection, but the blood smear quality had diminished sufficiently to yield inaccurate results. Therefore, total WBC counts are not reported. Fortunately, the WBC differentials and hemoparasite evaluations were performed in a timely manner after sample collection while the cells were easily identifiable. The authors speculate that the marine environment was detrimental to the slides, and that the lack of cover slips further caused cell deterioration. The leukocyte differentials for the Galápagos penguin population, combining male and females (n = 83), fell within the ranges reported for wild Humboldt penguins (Wallace et al., 1995). The clinical significance of the elevated eosinophil count in female Galápagos penguins remains unknown. Galápagos penguins were evaluated over two distinct environmental seasons, but no seasonal difference was found in eosinophil counts. Furthermore, eosinophil values between microfilarid positive and negative penguins did not differ.
Extraerythrocytic microfilariae were detected in the Galápagos penguins. Similar microfilariae have been detected in the flightless cormorant (Phalacrocorax harrisi) which shares the same geographic distribution as the penguins (Travis et al., 2006). Filarids are usually incidental findings (Greiner and Ritchie, 1994), and are rarely reported in penguins. There is only one known case of filariasis in Galápagos penguins (Chabaud and Ball, 1964). A detailed investigation is currently underway to further classify and characterize the microfilaria seen in 22% of the Galápagos penguins. The Eimeria oocysts found in one penguin fecal sample are not considered significant in a healthy bird. Coccidial infections have been reported as incidental findings in little penguins (Eudyptula minor) (Obendorf and McColl, 1980; Harrigan, 1992). Evaluating the impact of these various parasites in the Galápagos penguins necessitates a long-term study.
The Galápagos penguins were seronegative for exposure to all tested viruses. The seronegative Mareks disease (herpesvirus) results concurred with a previous study (Miller et al., 2001). Because most tests have been validated for domestic chickens, serologic results should be interpreted with caution. The Galápagos penguins were seropositive for C. psittaci (89%, 75/84). Chlamydophila psittaci is found worldwide in asymptomatic birds (Gerlach, 1994) and antibodies have been detected in multiple penguin species (Sieburth, 1958; Moore and Cameron, 1969; Wallace et al., 1997; Karesh et al., 1999). An outbreak at a zoo in the USA in a Spheniscus penguin species revealed that C. psittaci can be an important penguin pathogen (Freeland Dunker, pers. comm.). The significance of seropositive Galápagos penguins in the absence of DNA from PCR is unclear. A false positive antibody result or a latent or inactive infection cannot be ruled out. Chlamydophila psittaci has been extensively studied in the Galápagos Islands and antibodies have been detected in flightless cormorants (Travis et al., 2006) and domestic chickens (Gottdenker et al., 2005), and chlamydial DNA has been detected in Galápagos doves (Zenaida galapagoensis; Padilla et al., 2004) and cormorants (Travis et al., 2006).
Chickens in the Galápagos Islands have tested positive for parasites and diseases for which penguins might be susceptible, including Newcastle disease (Gottdenker et al., 2005). Although this study suggests that Galápagos penguins have not been exposed to poultry pathogens, the threat of pathogen transmission is real. Chickens range freely in Puerto Villamil on Southern Isabela and they have been observed on beachfront properties adjacent to where a small penguin population resides (Vargas and Wiedenfeld, 2004). Recent surveys suggest that penguin numbers are slowly increasing at this site through migration (Vargas, unpubl. data); therefore, measures should be implemented to reduce or prevent contact between penguins and poultry.
We report the most extensive West Nile virus (WNV) monitoring in the archipelago to date with negative results for the Galápagos penguins, flightless cormorants (Travis et al., 2006), and domestic chickens (Gottdenker et al., 2005). WNV is an emerging threat to naïve avian populations especially where known mosquito vectors reside (Peck et al., 1998; Turell et al., 2001). Because penguins are susceptible to WNV and mortality has been confirmed in black-footed (Spheniscus demersus) and Humboldt penguins (Centers for Disease Control, 2005), monitoring and prevention programs for WNV are in place or being devised for the Galápagos Islands.
A Population and Habitat Viability Analysis (PHVA) workshop was conducted on the Galápagos penguin facilitated by the Conservation Breeding Specialist Group (CBSG) of the International Union for Conservation of Nature (Matamoros et al., 2006). This workshop prioritized oil spills, strong El Niño events, and diseases among the top threats to the Galápagos penguin. Anthropogenic (fishing, tourism, oil spills) and climatic factors can stress fauna which can precipitate disease. The Galápagos National Park monitors and controls activities in the marine reserve to lessen negative impacts on the fragile ecosystem, and to assist in this monitoring, we provide the first comprehensive health information for the Galápagos penguin. Because the penguins are immunologically naïve to all viruses tested, a viral agent, especially one of high virulence, could be devastating. Even though the penguin population is slowly recovering after the crashes caused by strong El Niño events, disease could jeopardize the survival of this species. Disease surveillance should continue, as well as the development of contingency plans in order to respond rapidly to new pathogens.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
| LITERATURE CITED |
|---|
|
|
|---|
BIRDLIFE INTERNATIONAL. 2000. Threatened birds of the world. Lynx Edicions and BirdLife International, Barcelona, Spain and Cambridge, UK, 43 pp.
BOERSMA, P. D. 1977. An ecological and behavioral study of the Galápagos Penguin. Living Bird 15: 4393.
CENTERS FOR DISEASE CONTROL AND PREVENTION. www.cdc.gov/ncidod/dvbid/westnile/birdspecies.htm. Accessed December 2005.
CHABAUD, A. G., AND G. H. BALL. 1964. Filaire cardiaque chez un manchot des Galápagos Spheniscus mendiculus. Annales de Parasitologie (Paris) 39: 621626.
CLARKE, J., AND K. KERRY. 2000. Diseases and parasites of penguins. Penguin Conservation 13: 524.
DEIN, F. J. 1986. Hematology. In Clinical avian medicine and surgery, G. J. Harrison and L. R. Harrison (eds.). W. B. Saunders, Philadelphia, Pennsylvania, pp. 174191.
FRIDOLFSSON, A. K., AND H. ELLEGREN. 1999. A simple and universal method for molecular sexing of non-ratite birds. Journal of Biology 30: 116121.
FUDGE, A. M. 2000. Avian complete blood count. In Laboratory medicine: Avian and exotic pets, A. M. Fudge (ed.). W. B. Saunders, Philadelphia, Pennsylvania, pp. 918.
GAUTHIER-CLERC, M., N. ETERRADOSSI, D. TOQUIN, M. GUITTET, G. KUNTZ, AND Y. LE MAHO. 2002. Serological survey of the king penguin, Aptenodytes patagonicus, in Crozet Archipelago for antibodies to infectious bursal disease, influenza A and Newcastle disease viruses. Polar Biology 25: 316319.
GERLACH, H. 1994. Chlamydia. In Avian medicine: Principles and application, B. W. Ritchie, G. J. Harrison and L. R. Harrison (eds.). Wingers Publishing, Lakeworth, Florida, pp. 984996.
GOTTDENKER, N. L., T. WALSH, H. VARGAS, J. MERKEL, G. U. JIMENEZ, R. E. MILLER, M. DAILEY, AND P. G. PARKER. 2005. Assessing the risks of introduced chickens and their pathogens to native birds in the Galápagos Archipelago. Biological Conservation 126: 429439.
GREINER, E. C., AND B. W. RITCHIE. 1994. Parasites. In Avian medicine: Principles and application, B. W. Ritchie, G. J. Harrison and L. R. Harrison (eds.). Wingers Publishing, Lakeworth, Florida, pp. 10071029.
HARRIGAN, K. E. 1992. Causes of mortality in little penguins Eudyptula minor in Victoria. Emu 91: 273277.
KARESH, W. B., M. M. UHART, E. FRERE, P. GANDINI, E. BRASELTON, H. PUCHE, AND R. A. COOK. 1999. Health evaluation of free-ranging rockhopper penguins (Eudyptes chrysocomes) in Argentina. Journal of Zoo and Wildlife Medicine 30: 2531.[Medline]
LONGMIRE, J. L., A. W. LEWIS, N. C. BROWN, J. M. BUCKINGHAM, L. M. LARK, M. D. JONES, L. J. MEINKE, J. MEYNE, R. L. RATCLIFF, F. A. RAY, R. P. WAGNER, AND R. K. MOYZIS. 1988. Isolation and molecular characterization of a highly polymorphic centromeric tandem repeat in the family Falconidae. Genomics 2: 1424.[Medline]
MATAMOROS, Y., H. VARGAS, O. BYERS, AND R. LACY. 2006. Taller de Análisis de Viabilidad de la Población y el Hábitat del Pingüino de Galápagos (Spheniscus mendiculus) 811 de Febrero, 2005. Puerto Ayora, Santa Cruz, Galápagos, Ecuador, IUCN/SSC Conservation Breeding Specialist Group, Apple Valley, Minnesota, pp. 1167.
MILLER, G. D., B. V. HOFKIN, H. SNELL, A. HAHN, AND R. D. MILLER. 2001. Avian malaria and Mareks Disease: Potential threats to Galápagos penguins Spheniscus mendiculus. Marine Ornithology 29: 4346.
MILLS, K., AND H. VARGAS. 1997. Current status, analysis of census methodology, and conservation of the Galápagos Penguin (Spheniscus mendiculus). Noticias de Galápagos 58: 815.
MOORE, B. W., AND A. S. CAMERON. 1969. Chlamydia antibodies in Antarctic fauna. Avian Diseases 13: 681684.[Medline]
OBENDORF, D. L., AND K. MCCOLL. 1980. Mortality in little penguins (Eudyptula minor) along the coast of Victoria, Australia. Journal of Wildlife Diseases 16: 251259.
PADILLA, L. R., K. P. HUYVAERT, J. MERKEL, R. E. MILLER, AND P. G. PARKER. 2003. Hematology, plasma chemistry, serology and Chlamydophila status of the waved albatross (Phoebastria irrorata) on the Galápagos Islands. Journal of Zoo and Wildlife Medicine 34: 278283.[Medline]
, D. SANTIAGO, J. F. MERKEL, R. E. MILLER, AND P. G. PARKER. 2004. Survey for Haemoproteus spp., Trichomonas gallinae, Chlamydophila psittaci, and Salmonella spp. in Galápagos Islands Columbiformes. Journal of Zoo and Wildlife Medicine 35: 6064.[Medline]
PECK, S. B., J. HERATY, B. LANDRY, AND B. J. SINCLAIR. 1998. Introduced insect fauna of an oceanic archipelago: The Gálapagos Islands, Ecuador. American Entomologist 44: 218237.
PIERSON, F. W. 2000. Laboratory techniques for avian hematology. In Schlams veterinary hematology, B. F. Feldman, J. G. Zinkl and N. C. Jain (eds.). Lippincott Williams & Wilkins, Philadelphia, Pennsylvania, pp. 11451146.
SIEBURTH, J. M. 1958. Respiratory flora and disease of Antarctic birds. Avian Diseases 2: 402408.
TRAVIS, E., F. H. VARGAS, J. MERKEL, N. GOTTDENKER, R. E. MILLER, AND P. G. PARKER. 2006. Hematology, Plasma Chemistry, and Serology of the Flightless Cormorant (Phalacrocorax harrisi) in the Galápagos Islands, Ecuador. Journal of Wildlife Diseases 42: 133141.
TURELL, M. J., M. R. SARDELIS, D. J. DOHM, AND M. L. OGUINN. 2001. Potential North American vectors of West Nile virus. Annals of the New York Academy of Sciences 951: 317324.
TUTTLE, A. D., T. G. ANDREADIS, S. FRASCA, AND J. L. DUNN. 2005. Eastern equine encephalitis in a flock of African penguins maintained at an aquarium. Journal of the American Veterinary Medical Association 12: 20592062.
TYE, A., H. SNELL, S. B. PECK, AND H. ADSERSEN. 2002. Outstanding terrestrial features of the Galápagos Archipelago. In Biodiversity vision of the Galápagos Islands. Charles Darwin Foundation and World Wildlife Fund, Puerto Ayora, Galápagos, pp. 1223..
VALLE, C. A., AND M. C. COULTER. 1987. Present status of the flightless cormorant, Galápagos penguin and greater flamingo populations in the Galápagos Islands, Ecuador, after the 198283 El Niño. Condor 89: 276289.
VARGAS, F. H., AND D. WIEDENFELD. 2004. Summary report: 2004 Penguin and cormorant survey. University of Oxford & Charles Darwin Foundation, Oxford, UK, pp. 12.
, C. LOUGHEED, AND H. SNELL. 2005. Population size and trends of the Galápagos penguin Spheniscus mendiculus. Ibis 147: 367374.
, S. HARRISON, S. REA, AND D. W. MACDONALD. 2006. Biological effects of El Niño on the Galápagos penguin. Biological Conservation 127: 107114.
WALLACE, R. S., J. A. TEARE, E. DIEBOLD, M. MICHAELS, AND M. J. WILLIS. 1995. Hematology and plasma chemistry values in free-ranging Humboldt penguins (Spheniscus humboldti) in Chile. Zoo Biology 14: 311316.
, J. A TEARE, M. MICHAELS, E. DIEBOLD, K. GRZYBOWSKI, AND M. J. WILLIS. 1997. Disease surveillance in free-ranging Humboldt penguins (Spheniscus humboldti) in Chile. In Proceedings: American Association of Zoo Veterinarians, C. K. Baer (ed.). Houston, Texas, pp. 284285.
WIKELSKI, M., J. FOUFOPOULOS, H. VARGAS, AND H. SNELL. 2004. Galápagos birds and diseases: Invasive pathogens as threats for island species. Ecology and Society 9: 514.
Received for publication 12 May 2005.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |